150452-18-9

150452-18-9 structure
150452-18-9 structure
  • Name: ER21355
  • Chemical Name: 1-[-4-[(1,3-benzodioxol-5-ylmethyl)amino]-6-chloro-2-quinazolinyl]-4-piperidine-carboxylic acid
  • CAS Number: 150452-18-9
  • Molecular Formula: C22H21ClN4O4
  • Molecular Weight: 440.88000
  • Catalog: Signaling Pathways Metabolic Enzyme/Protease Phosphodiesterase (PDE)
  • Create Date: 2018-02-10 09:58:03
  • Modify Date: 2024-01-07 18:01:46
  • ER21355 is an inhibitor of phosphodiesterase 5 (PDE5), used for treatment of prostatic diseases.

Name 1-[-4-[(1,3-benzodioxol-5-ylmethyl)amino]-6-chloro-2-quinazolinyl]-4-piperidine-carboxylic acid
Synonyms 1-{4-[(Benzo[1,3]dioxol-5-ylmethyl)-amino]-6-chloro-quinazolin-2-yl}-piperidine-4-carboxylic acid
E4021
1-[4-[(1,3-benzodioxol-5-ylmethyl)amino]-6-chloro-2-quinazolinyl]-4-piperidinecarboxylic acid
6-chloro-4-(1,3-dioxaindan-5-yl)methylamino-2 (4-carboxy-1-piperidinyl)-quinazoline
1-[-4-[(1,3-benzodioxol-5-ylmethyl)amino]-6-chloro-2-quinazolinyl]-4-piperidine-carboxylic Acid
2-(4-carboxypiperidino)-4-(3,4-methylenedioxybenzyl)amino-6-chloroquinazoline
1-[6-chloro-4-(3,4-methylenedioxybenzyl)aminoquinazolin-2-yl)piperidine-4-carboxylic acid
ER21355
Description ER21355 is an inhibitor of phosphodiesterase 5 (PDE5), used for treatment of prostatic diseases.
Related Catalog
References

[1]. Wolf-Georg Forssmann, et al. Use of phosphodiesterase inhibitors in the treatment of prostatic diseases. US 8106061 B2

Molecular Formula C22H21ClN4O4
Molecular Weight 440.88000
Exact Mass 440.12500
PSA 96.81000
LogP 4.06300
Storage condition 2-8℃